330 related articles for article (PubMed ID: 32375301)
1. Pediatric Low-Grade Gliomas.
Collins KL; Pollack IF
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32375301
[TBL] [Abstract][Full Text] [Related]
2. Benign Glioma.
Wu PB; Filley AC; Miller ML; Bruce JN
Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
[TBL] [Abstract][Full Text] [Related]
3. Circumscribed astrocytic gliomas: Contribution of molecular analyses to histopathology diagnosis in the WHO CNS5 classification.
Köy Y; Tihan T
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S33-S41. PubMed ID: 35562132
[TBL] [Abstract][Full Text] [Related]
4. [Circumscribed Astrocytic Gliomas].
Hayashi H; Iwashita H; Tateishi K
No Shinkei Geka; 2023 Sep; 51(5):884-891. PubMed ID: 37743340
[TBL] [Abstract][Full Text] [Related]
5. Pathologic and molecular aspects of anaplasia in circumscribed gliomas and glioneuronal tumors.
Pujadas E; Chen L; Rodriguez FJ
Brain Tumor Pathol; 2019 Apr; 36(2):40-51. PubMed ID: 30859342
[TBL] [Abstract][Full Text] [Related]
6. Characterization of gliomas: from morphology to molecules.
Ferris SP; Hofmann JW; Solomon DA; Perry A
Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
[TBL] [Abstract][Full Text] [Related]
8. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
Wirsching HG; Weller M
Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
[TBL] [Abstract][Full Text] [Related]
9. The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas.
Dasgupta T; Haas-Kogan DA
Front Oncol; 2013; 3():110. PubMed ID: 23717811
[TBL] [Abstract][Full Text] [Related]
10. Low Grade Gliomas in Children.
Chalil A; Ramaswamy V
J Child Neurol; 2016 Mar; 31(4):517-22. PubMed ID: 26286938
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Gliomas: Molecular Landscape and Emerging Targets.
Peeters SM; Muftuoglu Y; Na B; Daniels DJ; Wang AC
Neurosurg Clin N Am; 2021 Apr; 32(2):181-190. PubMed ID: 33781501
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis.
Appin CL; Brat DJ
Adv Anat Pathol; 2015 Jan; 22(1):50-8. PubMed ID: 25461780
[TBL] [Abstract][Full Text] [Related]
13. Biomarker-driven diagnosis of diffuse gliomas.
Appin CL; Brat DJ
Mol Aspects Med; 2015 Nov; 45():87-96. PubMed ID: 26004297
[TBL] [Abstract][Full Text] [Related]
14. A case of high-grade astrocytoma with BRAF and ATRX mutations following a long-standing course over two decades.
Nakata S; Horiguchi K; Ishiuchi S; Yoshimoto Y; Yamada S; Nobusawa S; Ikota H; Hirato J; Yokoo H
Neuropathology; 2017 Aug; 37(4):351-357. PubMed ID: 28185325
[TBL] [Abstract][Full Text] [Related]
15. Pediatric-type diffuse low grade gliomas: Histomolecular profile and practical approach to their integrated diagnosis according to the WHO CNS5 classification.
Purkait S; Mahajan S; Sharma MC; Sarkar C; Suri V
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S42-S49. PubMed ID: 35562133
[TBL] [Abstract][Full Text] [Related]
16. Review on neuroimaging in pediatric-type diffuse low-grade gliomas.
Chen J; Qi X; Zhang M; Zhang J; Han T; Wang C; Cai C
Front Pediatr; 2023; 11():1149646. PubMed ID: 37920791
[TBL] [Abstract][Full Text] [Related]
17. Pediatric low-grade gliomas: implications of the biologic era.
Packer RJ; Pfister S; Bouffet E; Avery R; Bandopadhayay P; Bornhorst M; Bowers DC; Ellison D; Fangusaro J; Foreman N; Fouladi M; Gajjar A; Haas-Kogan D; Hawkins C; Ho CY; Hwang E; Jabado N; Kilburn LB; Lassaletta A; Ligon KL; Massimino M; Meeteren SV; Mueller S; Nicolaides T; Perilongo G; Tabori U; Vezina G; Warren K; Witt O; Zhu Y; Jones DT; Kieran M
Neuro Oncol; 2017 Jun; 19(6):750-761. PubMed ID: 27683733
[TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
[TBL] [Abstract][Full Text] [Related]
19. Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.
Fernández MB; Alonso VP
Childs Nerv Syst; 2016 Oct; 32(10):1939-45. PubMed ID: 27659836
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
